Novel Oral Anticoagulants for the Prevention of Stroke

Dosing of NOACs in non-valvular atrial fibrillation.

Prescribe the appropriate anticoagulant dose to prevent stroke in your patients with non-valvular atrial fibrillation, using the MIMS novel oral anticoagulants table.

This quick-reference table summarises dose regimens and adjustments, and instructions for switching from warfarin, for:

  • Apixaban (Eliquis)
  • Dabigatran (Pradaxa)
  • Edoxaban (Lixiana)
  • Rivaroxaban (Xarelto)

Drug names link through to the full MIMS entries for more detailed prescribing information on each product.

Information is summarised from manufacturers' Summaries of Product Characteristics (SPCs), available at medicines.org.uk.

.Go to the MIMS novel oral anticoagulants table

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more